03-11-2021

03-11-2021

01 Dr. Karagiannakis - HCC patients: The role of the MDT in the patient journey - BCLC B to BCLC C? Which is the right time for systemic treatment?

01 Dr. Karagiannakis - HCC patients: The role of the MDT in...

02 Dr. Zarkavelis - Treatment algorithm in HCC based on the updated guidelines. Which is the optimal sequencing after 1st line based on MoA of the current agents? -

02 Dr. Zarkavelis - Treatment algorithm in HCC based on the...

03 Dr. Agorastou - TKIs safety : Are TKI AEs predictable and manageable based on the long experience in HCC treatment? -

03 Dr. Agorastou - TKIs safety : Are TKI AEs predictable and...

04 Dr. Katsaounis - Are there any special AEs in Immunotherapy - Do we need a MDT approach?

04 Dr. Katsaounis - Are there any special AEs in Immunothera...

05 Dr. Barla - Special Patient segments with HCC - The view of the Gastroenterologist -

05 Dr. Barla - Special Patient segments with HCC - The view...

06 Dr. Rigakos - The view of the Oncologist -

06 Dr. Rigakos - The view of the Oncologist -

07 Prof. Gatselis - Management of HCC during COVID-19-The Greek experience

07 Prof. Gatselis - Management of HCC during COVID-19-The Gr...

livemed white